Literature DB >> 3148994

Depressed PPD and tetanus toxoid presentation by monocytes to T lymphocytes in patients with rheumatoid arthritis: restoration by interferon gamma.

M Seitz1, I Napierski, H Kirchner.   

Abstract

A diminished antigen presentation of blood monocytes to autologous T cells has been recently described in patients with rheumatoid arthritis (RA). In this study the defective presentation of common recall antigens by blood monocytes revealed it to be a monocyte dysfunction specific for RA which could not be found in other chronic inflammatory rheumatic or non-rheumatic diseases and which could be restored by recombinant human interferon gamma. In addition, RA monocytes in blood exhibited a strongly reduced expression of HLA-DR determinants on the cell surface. T cells from RA patients produced almost normal interleukin-2 (IL-2) levels and showed a normal IL-2 sensitivity after phytohemagglutinin (PHA) stimulation. Several reasons may be responsible for this altered monocyte function in RA. Among these an in vivo "preactivation" of monocytes associated with a reduced antigen-presenting capacity or an impaired regulation of monocyte/macrophage differentiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148994     DOI: 10.1007/bf00269194

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma.

Authors:  E M Lemmel; M Franke; W Gaus; P W Hartl; P H Hofschneider; K Miehlke; K Machalke; H J Obert
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

2.  Immunglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells.

Authors:  E Munthe; J B Natvig
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

3.  Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis.

Authors:  M Seitz; I Napierski; R Augustin; W Hunstein; H Kirchner
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

4.  Characterization of blood mononuclear cells of rheumatoid arthritis patients. II. Depressed PPD presentation by monocytes to T lymphocytes.

Authors:  M Seitz; P Vogt; W Müller; W Hunstein; D Gemsa
Journal:  Clin Immunol Immunopathol       Date:  1983-11

5.  Endogenous peroxidase in the nuclear envelope and endoplasmic reticulum of human monocytes in vitro: association with arachidonic acid metabolism.

Authors:  W Deimann; M Seitz; D Gemsa; H D Fahimi
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

6.  Demonstration of Ia antigens on certain dendritic cells and on a novel elongate cell found in human synovial tissue.

Authors:  R J Winchester; G R Burmester
Journal:  Scand J Immunol       Date:  1981-10       Impact factor: 3.487

7.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue.

Authors:  L Klareskog; U Forsum; U K Malmnäs Tjernlund; D Kabelitz; A Wigren
Journal:  Scand J Immunol       Date:  1981-08       Impact factor: 3.487

9.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro.

Authors:  R M Steinman; G Kaplan; M D Witmer; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  7 in total

1.  Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.

Authors:  G J McColl; J Hammer; L C Harrison
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

2.  Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness.

Authors:  L Berg; J Rönnelid; L Klareskog; A Bucht
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

3.  Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis.

Authors:  K E Kempsell; C J Cox; A A McColm; J A Bagshaw; R Reece; D J Veale; P Emery; J D Isaacs; J S Gaston; J S Crowe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Expression and function of CD5 and CD28 in patients with rheumatoid arthritis.

Authors:  J Verwilghen; V Corrigall; R M Pope; R Rodrigues; G S Panayi
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Depressed T-cell reactivity to recall antigens in rheumatoid arthritis.

Authors:  J Verwilghen; S Vertessen; E A Stevens; J Dequeker; J L Ceuppens
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

6.  T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles.

Authors:  Soi Cheng Law; Shayna Street; Chien-Hsiung Alan Yu; Christelle Capini; Sakoontalla Ramnoruth; Hendrik J Nel; Eline van Gorp; Claire Hyde; Kim Lau; Helen Pahau; Anthony W Purcell; Ranjeny Thomas
Journal:  Arthritis Res Ther       Date:  2012-05-17       Impact factor: 5.156

7.  Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.

Authors:  L Berg; J Rönnelid; C B Sanjeevi; J Lampa; L Klareskog
Journal:  Arthritis Res       Date:  2000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.